Many pharmaceutical companies now have personnel changes! Including chairman, deputy general manager and other positions

With the advancement of medical reform policies such as centralized procurement, pharmaceutical companies are under constant pressure, and the road to transformation has been accelerated.
In this process, a series of management changes have been accompanied
.
Since 2021, news about changes in corporate executives in the pharmaceutical industry has continued to be frequent.
According to incomplete statistics, since September, more than 20 executives of pharmaceutical companies have announced their resignations, involving more than 10 pharmaceutical companies, and many of their positions are directors.
long, deputy general manager, vice president and so on
.
In addition, some pharmaceutical companies, such as China Pharmaceuticals and China Resources Sanjiu, even announced the resignation of several senior executives within one day
.
Kangmei Pharmaceutical: Supervisor resigns On September 17, Kangmei Pharmaceutical issued an announcement stating that due to personal reasons, Zhong Shaozhu resigned as employee supervisor of the company
.
Before the election of the new employee supervisor, Zhong Shaozhu will still perform his duties as a supervisor
.
After resignation, Zhong Shaozhu still holds other positions in the company
.
BeiGene: Senior Vice President and Chief Commercial Officer of Greater China Resigned On September 16, Wu Qingyi, Senior Vice President of BeiGene and Chief Commercial Officer of Greater China, announced that he would leave the company to seek external development opportunities.
His work will expire in 2021.
October 1 of the year
.
According to data, Wu Qingyi officially joined BeiGene on June 19, 2019, as the Chief Commercial Officer of BeiGene Greater China
.
Stellite: Chairman resigns On September 16, Stellite announced that due to age reasons, Chairman Hu Jinsheng proposed to the board of directors to resign as chairman, and he will continue to serve as a director and a member of the board's strategy committee in the future
.
At the same time, the board of directors agreed to elect Hu Jian as the new chairman and chairman of the board's strategy committee, and to remove his vice chairman
.
Yi Rui Bio: Securities Affairs Representative Resigns Yi Rui Bio announced on the evening of September 17 that the company’s board of directors recently received a resignation report from the company’s securities affairs representative, Mr.
Zhou Ziyu, who applied to resign from the company’s securities affairs representative due to personal reasons.
After resignation, he will no longer hold any position in the company
.
Peking University Pharmaceutical: Non-independent director resigns On September 17, Peking University Pharmaceutical issued an announcement stating that the company’s board of directors received a written resignation report from the company’s director Fan Jing on September 17, 2021.

.
Fan Jing applied to resign as a director of the company due to personal reasons and no longer holds any position in the company
.
China Pharmaceuticals: 4 senior executives resigned.
On September 15, China Pharmaceuticals issued two announcements of personnel changes in a row.
The announcements showed that due to work adjustments, Jin Hongyan and Xu Yi applied to resign from the company’s directors and special committees of the board of directors.
No longer hold any positions in the company; Li Kehong and Feng Songtao applied to resign from the positions of supervisors of the company and no longer hold any positions in the company
.
At the same time, the company nominated Mr.
Zhou Xingbing and Ms.
Hu Huidong as director candidates, and Mr.
Chen Zheng and Mr.
Wang Yaliang as the company’s supervisor candidates
.
Yuandong Biology: Chief Scientist of the Chemical Medicine Research Department resigns On September 12, Yuandong Biology issued an announcement saying that the company’s core technical staff, Mr.
Liu Hua, recently applied for resignation due to personal reasons and completed the resignation procedures
.
After resignation, Liu Hua no longer holds any position in the company
.
Gan Li Pharmaceuticals: Deputy General Manager Resigns On September 10, the board of directors of Gan Li Pharmaceuticals received a "Letter of Resignation" from Deputy General Manager Lawrence Allan Hill.
Lawrence Allan Hill applied to resign from the position of Deputy General Manager of the company due to personal reasons
.
Lawrence Allan Hill's resignation is effective September 30, 2021
.
Lawrence Allan Hill will no longer hold any position in the company after his resignation
.
China Resources Sanjiu: Three Senior Executives Resigned On the evening of September 10, China Resources Sanjiu issued an announcement regarding the resignation of senior executives
.
According to the announcement, the company’s board of directors recently received a resignation report from directors Guo Wei, Deng Ronghui, and vice president Tan Ying
.
Due to job changes, Guo Wei proposed to resign as a director of the company's eighth board of directors and a member of the audit committee of the board of directors, Deng Ronghui proposed to resign as a director of the company's eighth board of directors, and Tan Ying proposed to resign from the company's vice president
.
After the resignation of the above three senior executives, they will no longer hold positions in the company
.
As of the date of this announcement, Guo Wei, Deng Ronghui, and Tan Ying do not hold the company’s stock
.
In addition to the above-mentioned pharmaceutical companies, there have also been news of personnel changes within the month, including Tebao Bio, Ruizhi Pharmaceutical, Beilu Pharmaceutical, Sinopharm, and Yuandong Biologics.
The industry expects that the changes in the management of pharmaceutical companies in the second half of the year may continue
.